Xortx Therapeutics Inc
(XRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 02-2011 | 11-2010 | 08-2010 | 05-2010 | 02-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,686 | 139,428 | 107,173 | 69,939 | 26,277 |
| Depreciation Amortization | 6,073 | 22,105 | 16,498 | 10,900 | 5,441 |
| Income taxes - deferred | -2,219 | N/A | -2,953 | -1 | N/A |
| Accounts receivable | 17,660 | -84,004 | -102,469 | -120,545 | -76,837 |
| Accounts payable and accrued liabilities | -15,907 | 59,178 | 116,801 | 104,674 | 84,384 |
| Other Working Capital | 12,245 | -95,884 | -77,552 | -72,146 | -28,964 |
| Other Operating Activity | 901 | 18,833 | -7,429 | 20,217 | -5,329 |
| Operating Cash Flow | $23,439 | $59,656 | $50,069 | $13,038 | $4,972 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,203 | -20,328 | -14,121 | -8,599 | -3,653 |
| Net Acquisitions | -5,380 | -4,908 | -4,908 | N/A | N/A |
| Purchase Sale Intangibles | -1,200 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -1,200 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-13,783 | $-25,236 | $-19,029 | $-8,599 | $-3,653 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -2,374 | 2,374 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 2,113 | 1,933 | 1,933 | 466 |
| Financing Cash Flow | $-2,374 | $4,487 | $1,933 | $1,933 | $466 |
| Beginning Cash Position | 90,842 | 51,935 | 51,935 | 51,935 | 51,935 |
| End Cash Position | 98,124 | 90,842 | 84,908 | 58,307 | 53,720 |
| Net Cash Flow | $7,282 | $38,907 | $32,973 | $6,372 | $1,785 |
| Free Cash Flow | |||||
| Operating Cash Flow | 23,439 | 59,656 | 50,069 | 13,038 | 4,972 |
| Capital Expenditure | -7,203 | -20,328 | -14,121 | -8,599 | -3,653 |
| Free Cash Flow | 16,236 | 39,328 | 35,948 | 4,439 | 1,319 |